chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had ringing in both ears, like my head's in a bowl & there's noise in it, like crickets or white noise; diarrhea; tired; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (I had ringing in both ears, like my head's in a bowl & there's noise in it, like crickets or white noise), DIARRHOEA (diarrhea), FATIGUE (tired), NAUSEA (nausea) and VOMITING (vomiting) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A, 029A21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, the patient experienced DIARRHOEA (diarrhea), FATIGUE (tired), NAUSEA (nausea) and VOMITING (vomiting). On 07-Nov-2021, the patient experienced TINNITUS (I had ringing in both ears, like my head's in a bowl & there's noise in it, like crickets or white noise). In November 2021, DIARRHOEA (diarrhea), FATIGUE (tired), NAUSEA (nausea) and VOMITING (vomiting) had resolved. At the time of the report, TINNITUS (I had ringing in both ears, like my head's in a bowl & there's noise in it, like crickets or white noise) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  On 03-Nov-2021, patient felt tired, had nausea, vomiting, diarrhea for 1 week - mostly in the mornings.  On 12-Nov-2021, Stated that the ringing in ears was worse today.  Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-386085, MOD-2021-386019 (Patient Link).
Cluster of 2 patients (patient identification provide) developed sore throat, neck stiffness, swollen glands and fever, after receiving Menactra (lot number U1567AA), received from a health care professional in the USA on 02 May 2007. A 17 year old female patient developed throat, stiffness in the next, swollen glands and fever, 5 days after receiving Menactra (lot number U1961A, route not reported) in the left arm on 25 April 2007. She had a CDC with differential performed. At the time of the vaccination, she did not have any illness. It was reported that the recovered. Follow-up received from the health professional on 17 May 2007 stated that there was "no additional information at the time". No further information expected. The second case from same reporter is detailed in case 2007-01503.
Patient fainted after receiving his vaccines.  During the fainting episode he also had a seizure (vascular).  Put on left side with cold compresses. After regained consciousness and sat up, needed to lay back down.  Not sure is lost consciousness second time.
103 Fever, severe chills, severe aches and pain through body, difficult to eat and drink, extreme fatigue
Patients received expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Patient received second Booster. vaccine expiration date 27 March 2022 Treatment details was not reported by the reporter.
High fever. 104 degrees. 2 children. swollen injection site. Injection site turned purple. Will not bear weight on legs.
Initially noted soreness in R arm within 48-72 hrs. On around 11/5 noticed a red "crusty" area on R arm and then on chest/stomach area. To this date 1/10/03 noted 12 round lesions on both arms and chest/abdominal area.
My heart rhythm was different from normal. I was experiencing PVC's. I could feel the irregularities of my heart beat. I also experienced dizzy spells and elevated anxiety. I was light headed. My physical activity was affected as I was anxious about my heart and short of breath. My vision was also affected and my beats per minutes were very high in a resting period. I took over part of my daily living, I went to see Cardiology and they dosed me with Metoprolol. I noticed a difference in a few weeks, My heart rhythm returned to its normal beats after 3 to 4 weeks. I am still taking the Metoprolol currently.
Hospitalized for Covid after full vaccination.  Acute hypoxemic respiratory failure due to COVID-19  Assessment & Plan Presented with 4 to 5 days of cough and fatigue. Subsequently became encephalopathic and lethargic. Was eating very little prior to admit. Found to be a bit hypoxic with volume contraction and hypokalemia as well. - Symptom onset: 10/25 - Date isolation discontinued 11/14 - Finished 10 day course of dexamethasone - Finished 5-day course of remdesivir - Now on room air  - DNR/DNI
Red and warm to touch, measuring 7 inches width and 6 inches length. Erythema and swelling on left shoulder, improved with ice pack. Instructed mother to return if spreading.
Pharmacist informed that it is not recommended to administer per prescribing information/AE filed for the potential that the doctor may still give it; This spontaneous report was received from a pharmacist and refers to a 49-years-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was prescribed with  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 mg intramuscularly (IM) x 1 dose for prophylaxis (frequency, lot number and expiration date were not provided) for a 49 years old patient (product prescribing issue). She also informed that the vaccine was not administered at the time. Pharmacist informed that it was not recommended to administer per prescribing information.
Received vaccine on 1/12/21. On 1/19/21, I woke up to a red splotchy rash on my left arm where I received the vaccine. I put cortisone cream on it, and that night I noticed it is now raised and more red. It does not itch or hurt.
no fever but fussy since shots;had spell @ 24hr & 40hr p/shots where became poorly perfused (mottled) cold extremities & blue lips;but recovered from both p/20-60min;inc RR, but mom assured secondary to fussiness & gas on belly;
Red rash blotches discovered all over breasts, under breasts, across stomach, along groin area, and a tiny splotches around the back - found in the morning (sunday 8am).  Did not itch  until I went into shower, water aggravates it.  By night-time (8pm)  same day, it spread to upper chest and neck area (font and back)  but is not visible blotches like the rest, skin just red looking and itchy. (but neck/chest very tan, so may just not be able to see the blotches honestly). This did not happen with Shot #1 on 4/2/21 at the same location. I tested positive for COVID-19 in August 2020, but it did NOT happen during that time either.
A mother reported that her son rec'd DTaP (manufacturer unknown) in 12/00. A few days post immunization he developed a fever of 99F
Information has been received from a physician and a practice manager via two company representatives referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 12-JUL-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml (lot # L010598, expiration date 06-AUG-2016, route unknown). The total cumulative excursion time was 24 hours with the highest recorded temperature of 47 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a medical assistant regarding an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. In approximately 2016 (reported as "unknown dates starting on or after 14-MAY-2016"), the patients were vaccinated with GARDASIL 9 injection (lot # L043213, expiration date 28-AUG-2017 (lot # L026602, expiration date 19-OCT-2017) (dose, route and anatomical location of administration were not reported), which were improperly stored at 53.2 F for 73 hours. There was no previous temperature excursion. The temperature excursion was detected by a digital data logger. No adverse effect was reported and no product quality complaint was involved. This is one of two cases received from the same source. Additional information has been requested.
Patient was encouraged to undergo Serogroup B Meningococcal Vaccination per CDC recommendation following two confirmed cases of Meningitis B at the University. After a week post vaccination characterized by general malaise (chills early, then predominantly tiredness), in the PM of Friday Dec 8 the patient suffered a series of Generalized Tonic-Clonic seizures in her dorm, accompanied by disorientation, confusion and possibly/eventually unconsciousness. Leading to an 9-1-1 call, ambulance transport to local hospital then immediately to the ER, where she was hospitalized in the Dept. of Neurology until discharge 4 days later.
This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender. On 06-JUL-2017, the patient was vaccinated with a dose of improperly stored VARIVAX (lot # M024681, expiration date 18-MAY-2018; dose and route unknown) for prophylaxis, which was reconstituted with the properly stored sterile diluent. The vaccine was exposed to temperature excursion of -14 degrees Celsius (C) to -10 C for 287.5 hours, -9 C to 8 C for 6 hours, and 9 C to 25 C for 24 hours. Data logger involved. There was no temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1707USA007696: US-009507513-1708USA005406:
AT 6 month shots - had some symptoms.  I did not know what it was.  3rd day after shots - stated waking up from naps screaming - like did not know where he was.  Takes 5 to 15 minutes to calm down.
cellulitis, erythematous, firm indurated warm area left arm 2 weeks post vaccination.  patient states received vaccine in left, documented on right.  Antibiotics given
I received COVID 19 Pfizer vaccine on 12/23/20 and on 12/27/20 my blood pressure started to spike with  readings 150's/100's while well controlled on  medication- Metoprolol 25 mg tab daily.  My BP remained elevated on 12/28 and i  subsequently went to the ER  and  had chest XRay; EKG and cardiac workup done with all tests negative.  I was instructed by ER Doctor to follow up with  my cardiologist- Dr. and he subsequently  changed my medication regimen to  Metoprolol 25 mg tab  twice daily.  Since  that episode my BP has been well controlled.  I  am not sure if there is a correlation with the vaccine.  However i am bringing to your attention as i have never had a spike in BP while on BP meds.
painful arm; arm is red and warm; arm is red and warm; hives on the arm and under the armpit.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (painful arm), ERYTHEMA (arm is red and warm), FEELING HOT (arm is red and warm) and URTICARIA (hives on the arm and under the armpit.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Liver transplant (Patient had liver transplant in 2012) in 2012.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (painful arm), ERYTHEMA (arm is red and warm), FEELING HOT (arm is red and warm) and URTICARIA (hives on the arm and under the armpit.). At the time of the report, PAIN IN EXTREMITY (painful arm), ERYTHEMA (arm is red and warm), FEELING HOT (arm is red and warm) and URTICARIA (hives on the arm and under the armpit.) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-101623.
PATIENT FELT DIZZY, LIGHT HEADED, AND THROAT WAS DRY AND ITCHING ON THE LEFT SIDE.
MISSED TO TAKE THIRD DOSE ON TIME; This spontaneous case report (PVX2019-2527) was received from a consumer on 09-Oct-2019. It described a male consumer who "missed to take third dose on time" (PT: Product dose omission), while being on oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer took the first and the second dose of Vivotif on 04-Oct-2019 and 06-Oct-2019 respectively. Then, he missed to take third dose, which was due on 08-Oct-2019.  Action taken with Vivotif with respect to reported event was not applicable.  The clinical outcome of the reported event was unknown  Company's Comment: The causality of the event "missed to take third dose on time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take third dose on time" was considered as not applicable.
After receiving the third dosage of Moderna in December, I have not had my menstrual cycle. I have never missed a period unless I am pregnant, and I am 100% sure that I am not pregnant at this time.
Within 45 minutes, the pressure in my head was intense.  I felt the need to press my hand against my forhead; as if it were going to burst.  I became very stuffy and smells were not lost; but rather, distorted.  Within the next few days, my menstrual cycle became erratic; and has been this way ever since (7 months now).  My period will come for 2 days, then gone.  Or will come every two weeks; with extreme varying in degree of cramping as well as flow.  This is atypical for me.  IThe extreme pressure in my head last 2 days.  Low grade fever for 3 days. Dizzyness on day 4 and 5.  Long term effects include the erratic menstural cycle, and frequent forgetting of names, words, and past events.
Received immunization at 9:00Am , around 2:30 pm started with crying spells lasting 1-3 hours and fever had continued with bouts of moderate irritability and crying.
Received the Moderna vaccine (shot 1) on 1/16/21 and developed cellulitis on 1/25/21. The day after shot area red and arm was sore and painful. Went away the following day. On 1/24/21 noticed my arm was hurting again it wasn't until 1/25/21 that the big red rash area was seen at shot site and grew up my arm and my hands developed rashes.
Immediately I had a bitter/metal taste at the end of my throat.  It last about 5 hours and and ended about 2:30-3:30pm. I had a bitter/metal taste when I ate anything or drank water.
I had vaccination on 09/23/2022. On 09/24/2022 I woke up with extreme fatigue. I have had the fatigue since the bivalent vaccination and still experiencing on 12/27/2022. I went to urgent care in 11/2022 and ran blood panel and thyroid tests. All tests came back normal. I have appointment on 02/22/2023 with a neurologist for the continuous headaches and test for autoimmune diseases.
Tested positive for Covid 19; Tested positive for Covid 19; This is a spontaneous report from a contactable consumer.  A 39-years-old female consumer (patient) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Mar2021 at  09:30 AM (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  Medical history included allergies to Pennicilin. The patient's concomitant medications were none in two weeks, no other vaccine in four weeks. On 10Jul2021 the patient started experiencing Covid-19 symptoms such as cough, loss of taste and smell, fatigue, headache, congestion. On 20Jul2021 the patient tested positive for COVID-19 via Nasal Swab test. No treatment was received. The outcome of the event was recovering.  Information about lot/batch has been requested.
I contracted COVID-19. I had a mild cough, fever, chills, sinus headache, and sinus congestion. I was extremely weak. I was prescribed Paxlovid, Mucinex and Flonase by my doctor. I still have a lingering cough. When I lie down at night, the cough gets worse. I have lung congestion.
Cellulitis - like local reaction to 2nd PNEUMOVAX dose (given >5 yrs after initial dose). Tx'd with ice packs, Levaquin 500mg PO Q24 hours x 5 days with marked improvement in 1st 24 hour of treatment.
Fever, body aches, shortness of breath, chills and sweats  Loss of tastes and  weird dreams
Nausea; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date, refer case US2019AMR167670).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced nausea. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the nausea was recovered/resolved.   It was unknown if the reporter considered the nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter's friend received dose of Shingrix and next day after vaccination experienced nausea. The nausea recovered within 1 days. The reporter did not provide additional details. This was 3rd of 4 reports provided by the reporter.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 3:17 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022 at 3:17 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28 Jan 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. Vaccination date was reported on 28 Jan 2022 at 15:17:17.The patient received booster dose. Its 30 days expiry date vaccine went into 2 to 8 °C thaw state on or about to 24-Dec-2021. No treatment information was reported.   This case was linked to MOD-2022-542869 (Patient Link).
Maroon top pfizer for ages 6 months through 4 years old was reconstituted incorrectly. It was reconstituted  with 1.3mL versus the recommended reconstitution of 2.2 mL on 07/12/22. No adverse reaction reported.
This is re: to the Pfizer booster, subsequent to receiving both doses of Moderna vaccine. Adverse effects lasted 4 days, include fever, joint aches, swollen/sore lymph nodes, exhaustion, dizziness, headache,, pain in ribs in back. I experienced adverse effects after the 2nd Moderna vaccine, but they only lasted 36 hours. I'm 4 days post-booster, and am still not feeling 100%.
In December of 2022 I began having symptoms where everything went dark and I almost fainted. A few days later, after the holidays, I felt very tired and had severe diarrhea. I also had chest pain. I went to urgent care. I was told I was probably dehydrated and was told to rest. A few days later I had chest pain again and went to the emergency department. I had chest X-ray, and it was normal. My quality of sleep got worse and was convinced I was severely dehydrated. I was urinating so much and did not have an appetite. I went to the emergency department again. The fatigue and lack of sleep continued. My insomnia was so bad I didn't sleep for several days. I would get so dizzy that I would nearly fall when I got up. I have poor short-term memory and complete brain fog. I sometimes have pressure in my right ear, blood in my nose and pressure in my nose. My menstrual cycle has changed, and I no longer have pain like I did before the booster. I had heart palpitations and a stiff left arm. I am currently seeing a therapist. I was unable to take care of myself, so I had to move in with my family. The therapist currently tells me my symptoms are caused by depression and/or anxiety. I am working new doctors in the area where my family lives.
feel like crap; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date:17-May-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient just received Shingles shot and felt like crap. The patient knew that it would not last.
On May 04, 2021 this 22-year-old male patient received his second COVID 19 vaccine on his right arm at 1705. On May 04, 2021 at 1755 the patient complained of pain at the injection site and was treated with acetaminophen 650 mg, the patient also requested acetaminophen on May 05, 2021 at 08:34, 14;49, and 20:50.   On May 07, 2021, I spoke to the provider who stated the patient has not complained of pain from the injection site
plaintiff alleges that w/in 10 days of vax OCT94 pt fell ill & was ultimately dx w/GBS;pt was hosp & has undergone rehabilitation;residual sx are reported to cont;
Received injection on 10/28/16. On 10/30/16 he started experiencing itching on his (L) hand with a rash (hives). The rash and itching would move to another area of body every day or 2. Never had a fever or difficulty breathing. Given prednisone taper on 11-17-16.